From Palm Leaves to Patents: Who Really Owns Ayurveda?

By Dr. Arun Chandan and Dr. Mamta Chandan

India’s ancient medical system, Ayurveda, has travelled an extraordinary journey – from the handwritten palm leaf to the global patent office. Long before the microscope, Indian vaidyas were classifying herbs by taste, potency and post-digestive effect, describing diseases and remedies with remarkable precision. That collective knowledge, refined over millennia, was always considered a shared cultural resource, not private property.

Today, the same knowledge sits at the heart of a modern scientific rush. Laboratories and companies worldwide are using bioinformatics and computational biology to decode the chemistry of Ayurvedic herbs and identify potential new drugs. Yet as this digital wave gathers speed, an uncomfortable question demands attention: who actually owns this knowledge?

The bioinformatics boom

In the past decade, a new discipline – Ayurinformatics – has fused Ayurveda with data science. Researchers now use molecular-docking algorithms to simulate how herbal compounds interact with human proteins. Databases such as IMPPAT 2.0 and SwissTargetPrediction store thousands of phytochemicals drawn from classical herbs like Ashwagandha and Guduchi.

This computational validation is exciting. Studies on Tinospora cordifolia have linked its alkaloids with anti-inflammatory and neuroprotective pathways, while digital modelling of Chandanasava, a classical formulation, has helped explain its effect on kidney and cardiac health. The language of rasa and virya is being translated into the grammar of genes and receptors. But this scientific renaissance also blurs the line between shared heritage and private ownership.

The lure of patents

In modern law, knowledge becomes property when it is patented. A patent confers monopoly rights only if an invention is novel and non-obvious. Yet most Ayurvedic formulations are already described in ancient texts or living traditions – what the law calls prior art. They belong to everyone.

Still, the temptation to privatise persists. The turmeric and neem patent controversies of the 1990s, and even the attempt to patent basmati rice, revealed how traditional Indian knowledge could be repackaged and claimed abroad. India fought and won those battles by showing historical evidence. The experience led to the creation of the Traditional Knowledge Digital Library (TKDL), which now lists more than 4 lakh formulations from Sanskrit, Arabic, Persian and Tamil sources. It allows patent offices worldwide to reject claims based on known remedies. The TKDL has protected India from foreign biopiracy. The challenge now lies within our own borders.

Patents without products

Since Independence, Indian scientists and institutions have filed thousands of patents on herbal and Ayurvedic leads. Yet only a handful reached the market. Many lack novelty; others have never been validated through rigorous pharmacological or clinical studies. Some struggle through overlapping regulatory frameworks of AYUSH, FSSAI and the Drugs and Cosmetics Act.

A more subtle barrier is ethical. When patents derive from community knowledge – the wisdom of traditional healers and forest gatherers – they often omit the real custodians. Ownership is claimed by laboratories; credit and benefit seldom reach the villages where the knowledge originated. In such cases, patents become monuments to exclusion rather than innovation.

LokAyurved: the living source

Beyond classical texts lies LokAyurved – the living stream of Ayurveda practiced by folk healers, tribal vaidyas and village elders. Their formulations are ecological, oral and adaptive. A healer in Kangra may treat arthritis with Nirgundi or gastritis with Patol Patra, just as his ancestors did. For him, knowledge is sacred and shared. “How can one patent a blessing from the forest?” he asks.

To protect such heritage, India’s Biological Diversity Act (2002) mandates Prior Informed Consent (PIC) and Access and Benefit Sharing (ABS) for any use of biological resources or associated knowledge. Communities are encouraged to record their practices in People’s Biodiversity Registers (PBRs) – a legal assertion of custodianship. Yet compliance remains weak. Few researchers disclose community sources; fewer still share benefits. Between digital science and rural silence lies a moral vacuum.

Bioinformatics: validation or vulnerability?

Bioinformatics can strengthen Ayurveda’s credibility by confirming its pharmacological logic. But the same digitisation can also expose heritage to exploitation. Once genomic or phytochemical data are online, foreign entities can file patents on derivatives or analogues under new chemical names. The line between validation and violation becomes dangerously thin.

India must therefore build digital ethics into its bioinformatics strategy — secure databases, clear attribution, and national sovereignty over biological data. Every dataset on medicinal plants should carry a traceable record of textual or community origin. The TKDL model must evolve into a next-generation Ayurvedic Bio-Resource Repository, combining traditional citations with molecular evidence.

A model for ethical innovation

In the Himalayan states, where biodiversity and traditional knowledge coexist, new models are emerging. Under the Regional-cum-Facilitation Centre (RCFC-NR-1), farmers are trained in Good Agricultural Practices for medicinal plants, and local healers help identify elite varieties. Digital traceability links each herbal product to its biological source and community partner. This framework aligns economic growth with ethical guardianship – turning validation into livelihood and conservation.

Such examples show that Ayurveda need not fear modern science. What it needs is fairness.

Learning from failures

Many government-funded patents have failed not for lack of science but for lack of conscience. A formulation that bypasses consent or proof quickly loses credibility. The lesson is clear: science without ethics is sterile; ethics without science is stagnant.

If researchers, policymakers and healers collaborate transparently – citing sources, sharing benefits and validating results – Ayurveda can stand as both evidence-based and equitable. That, not aggressive patenting, will secure its global respect.

Guarding the soul of Ayurveda

In the noise of commercialisation, we must not forget Ayurveda’s first principle: Lokānām hita kārī āyurvedaḥ – the science that exists for the welfare of all beings. Its purpose was never profit but healing. Modern tools like AI and bioinformatics should serve that spirit, not replace it. Technology must strengthen the roots, not sever them.

Across the world, nations with traditional systems face the same dilemma. Who owns heritage in the digital age? The answer, for India at least, is moral as much as legal. Ayurveda belongs to its people, its forests, and its timeless philosophy of balance. Scientists and policymakers are merely trustees of this inheritance.

The road ahead

India’s leadership in creating the TKDL and enforcing the Biological Diversity Act gives it a moral edge in global debates on traditional knowledge. The next step is to make ethical innovation our national standard. Every herbal discovery should acknowledge its classical or community roots, ensure fair benefit-sharing, and remain open to independent validation.

As the world turns to Ayurveda for sustainable health, India must demonstrate that science and conscience can walk together. From palm leaves to patents, the journey of Ayurveda should not be a tale of ownership – but of guardianship.

Authorship: Dr. Arun Chandan & Dr. Mamta Chandan

doctorchandan@gmail.com 7018001026

About the authors:
Dr. Arun Chandan is an Ayurvedic physician and Principal Investigator, Regional-cum-Facilitation Centre (North Region-I),National Medicinal Plants Board  Ministry of AYUSH at Research Institute in Indian Systems of Medicine(RIISM) Joginder Nagar.  Dr. Mamta Chandan is an Ayurvedic clinician and Panchkarma specialist with the AYUSH Health & Wellness Centre, Rajol, Himachal Pradesh. Both write on Ayurveda, biodiversity, and ethics in science.